COVID-19 Impact on Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, Status and Forecast 2020-2026

August 2020 | 96 pages | ID: C76AEC7A2707EN
QYResearch

Abstracts

This report focuses on the global Rx Irritable Bowel Syndrome (IBS) Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Rx Irritable Bowel Syndrome (IBS) Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Ironwood Pharmaceuticals
• Bausch Health
• Takeda
• Sebela Pharmaceuticals
• Allergan

Market segment by Type, the product can be split into

• IBS-D Drugs
• IBS-C Drugs
• Others

Market segment by Application, split into

• Women
• Men

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Rx Irritable Bowel Syndrome (IBS) Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Rx Irritable Bowel Syndrome (IBS) Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Rx Irritable Bowel Syndrome (IBS) Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 IBS-D Drugs
  1.4.3 IBS-C Drugs
  1.4.4 Others
1.5 Market by Application
  1.5.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Women
  1.5.3 Men
1.6 Coronavirus Disease 2019 (Covid-19): Rx Irritable Bowel Syndrome (IBS) Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Rx Irritable Bowel Syndrome (IBS) Drugs Industry
    1.6.1.1 Rx Irritable Bowel Syndrome (IBS) Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Rx Irritable Bowel Syndrome (IBS) Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Rx Irritable Bowel Syndrome (IBS) Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Rx Irritable Bowel Syndrome (IBS) Drugs Market Perspective (2015-2026)
2.2 Rx Irritable Bowel Syndrome (IBS) Drugs Growth Trends by Regions
  2.2.1 Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Rx Irritable Bowel Syndrome (IBS) Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Rx Irritable Bowel Syndrome (IBS) Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Rx Irritable Bowel Syndrome (IBS) Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Market Size
  3.1.1 Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Revenue (2015-2020)
  3.1.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Concentration Ratio
  3.2.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue in 2019
3.3 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players Head office and Area Served
3.4 Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Product Solution and Service
3.5 Date of Enter into Rx Irritable Bowel Syndrome (IBS) Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Historic Market Size by Type (2015-2020)
4.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Type (2021-2026)

5 RX IRRITABLE BOWEL SYNDROME (IBS) DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020)
5.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2015-2020)
6.2 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players in North America (2019-2020)
6.3 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020)
6.4 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2015-2020)
7.2 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players in Europe (2019-2020)
7.3 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020)
7.4 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2015-2020)
8.2 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players in China (2019-2020)
8.3 China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020)
8.4 China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2015-2020)
9.2 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players in Japan (2019-2020)
9.3 Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020)
9.4 Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2015-2020)
10.2 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2015-2020)
11.2 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players in India (2019-2020)
11.3 India Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020)
11.4 India Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2015-2020)
12.2 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020)
12.4 Central & South America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Ironwood Pharmaceuticals
  13.1.1 Ironwood Pharmaceuticals Company Details
  13.1.2 Ironwood Pharmaceuticals Business Overview and Its Total Revenue
  13.1.3 Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
  13.1.4 Ironwood Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020))
  13.1.5 Ironwood Pharmaceuticals Recent Development
13.2 Bausch Health
  13.2.1 Bausch Health Company Details
  13.2.2 Bausch Health Business Overview and Its Total Revenue
  13.2.3 Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
  13.2.4 Bausch Health Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020)
  13.2.5 Bausch Health Recent Development
13.3 Takeda
  13.3.1 Takeda Company Details
  13.3.2 Takeda Business Overview and Its Total Revenue
  13.3.3 Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
  13.3.4 Takeda Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020)
  13.3.5 Takeda Recent Development
13.4 Sebela Pharmaceuticals
  13.4.1 Sebela Pharmaceuticals Company Details
  13.4.2 Sebela Pharmaceuticals Business Overview and Its Total Revenue
  13.4.3 Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
  13.4.4 Sebela Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020)
  13.4.5 Sebela Pharmaceuticals Recent Development
13.5 Allergan
  13.5.1 Allergan Company Details
  13.5.2 Allergan Business Overview and Its Total Revenue
  13.5.3 Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
  13.5.4 Allergan Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020)
  13.5.5 Allergan Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Rx Irritable Bowel Syndrome (IBS) Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue
Table 3. Ranking of Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of IBS-D Drugs
Table 6. Key Players of IBS-C Drugs
Table 7. Key Players of Others
Table 8. COVID-19 Impact Global Market: (Four Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Rx Irritable Bowel Syndrome (IBS) Drugs Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Rx Irritable Bowel Syndrome (IBS) Drugs Players to Combat Covid-19 Impact
Table 13. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Regions (2015-2020)
Table 17. Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Rx Irritable Bowel Syndrome (IBS) Drugs Market Growth Strategy
Table 23. Main Points Interviewed from Key Rx Irritable Bowel Syndrome (IBS) Drugs Players
Table 24. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Players (2015-2020) (Million US$)
Table 25. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Players (2015-2020)
Table 26. Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs as of 2019)
Table 27. Global Rx Irritable Bowel Syndrome (IBS) Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Product Solution and Service
Table 30. Date of Enter into Rx Irritable Bowel Syndrome (IBS) Drugs Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020) (Million US$)
Table 33. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Share by Type (2015-2020)
Table 34. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2021-2026)
Table 35. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Share by Application (2015-2020)
Table 36. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020) (Million US$)
Table 37. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Share by Application (2021-2026)
Table 38. North America Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Market Share (2019-2020)
Table 40. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020) (Million US$)
Table 41. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2015-2020)
Table 42. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020) (Million US$)
Table 43. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2015-2020)
Table 44. Europe Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Market Share (2019-2020)
Table 46. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2015-2020)
Table 48. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2015-2020)
Table 50. China Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (2019-2020) (Million US$)
Table 51. China Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Market Share (2019-2020)
Table 52. China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020) (Million US$)
Table 53. China Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2015-2020)
Table 54. China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020) (Million US$)
Table 55. China Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2015-2020)
Table 56. Japan Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Market Share (2019-2020)
Table 58. Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2015-2020)
Table 60. Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Market Share (2019-2020)
Table 64. Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2015-2020)
Table 66. Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2015-2020)
Table 68. India Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (2019-2020) (Million US$)
Table 69. India Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Market Share (2019-2020)
Table 70. India Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020) (Million US$)
Table 71. India Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2015-2020)
Table 72. India Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020) (Million US$)
Table 73. India Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Market Share (2019-2020)
Table 76. Central & South America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2015-2020)
Table 78. Central & South America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2015-2020)
Table 80. Ironwood Pharmaceuticals Company Details
Table 81. Ironwood Pharmaceuticals Business Overview
Table 82. Ironwood Pharmaceuticals Product
Table 83. Ironwood Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020) (Million US$)
Table 84. Ironwood Pharmaceuticals Recent Development
Table 85. Bausch Health Company Details
Table 86. Bausch Health Business Overview
Table 87. Bausch Health Product
Table 88. Bausch Health Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020) (Million US$)
Table 89. Bausch Health Recent Development
Table 90. Takeda Company Details
Table 91. Takeda Business Overview
Table 92. Takeda Product
Table 93. Takeda Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020) (Million US$)
Table 94. Takeda Recent Development
Table 95. Sebela Pharmaceuticals Company Details
Table 96. Sebela Pharmaceuticals Business Overview
Table 97. Sebela Pharmaceuticals Product
Table 98. Sebela Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020) (Million US$)
Table 99. Sebela Pharmaceuticals Recent Development
Table 100. Allergan Company Details
Table 101. Allergan Business Overview
Table 102. Allergan Product
Table 103. Allergan Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020) (Million US$)
Table 104. Allergan Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type: 2020 VS 2026
Figure 2. IBS-D Drugs Features
Figure 3. IBS-C Drugs Features
Figure 4. Others Features
Figure 5. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application: 2020 VS 2026
Figure 6. Women Case Studies
Figure 7. Men Case Studies
Figure 8. Rx Irritable Bowel Syndrome (IBS) Drugs Report Years Considered
Figure 9. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Regions: 2020 VS 2026
Figure 11. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Players in 2019
Figure 14. Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue in 2019
Figure 16. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Ironwood Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Ironwood Pharmaceuticals Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020)
Figure 25. Bausch Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Bausch Health Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020)
Figure 27. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Takeda Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020)
Figure 29. Sebela Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Sebela Pharmaceuticals Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020)
Figure 31. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Allergan Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2015-2020)
Figure 33. Bottom-up and Top-down Approaches for This Report
Figure 34. Data Triangulation
Figure 35. Key Executives Interviewed